Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Solian 100
Active Ingredient: Amisulpride 100mg
Dosage Form: Tablet
New Zealand Sponsor: Sanofi-Synthelabo (NZ) Limited
Manufacturers: Sanofi Winthrop Industrie, Quetigny, France
Sanofi-Synthelabo Limited, Fawdon, Newcastle-upon-Tyne, Tyne & Wear, United Kingdom
Product: Solian 200
Active Ingredient: Amisulpride 200mg
Dosage Form: Tablet
New Zealand Sponsor: Sanofi-Synthelabo (NZ) Limited
Manufacturers: Sanofi Winthrop Industrie, Quetigny, France
Sanofi-Synthelabo Limited, Fawdon, Newcastle-upon-Tyne, Tyne & Wear, United Kingdom
Product: Solian 50
Active Ingredient: Amisulpride 50mg
Dosage Form: Tablet
New Zealand Sponsor: Sanofi-Synthelabo (NZ) Limited
Manufacturers: Sanofi Winthrop Industrie, Quetigny, France
Sanofi-Synthelabo Limited, Fawdon, Newcastle-upon-Tyne, Tyne & Wear, United Kingdom
Dated this 12th day of January 2006.
BARRY BORMAN, Acting-Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).